111 related articles for article (PubMed ID: 32563755)
1. Rash in the acute setting not always easy.
Iqbal B; Alonso JV; Raza TH
Hematol Transfus Cell Ther; 2021; 43(3):371-373. PubMed ID: 32563755
[No Abstract] [Full Text] [Related]
2. Rash in multicenter trials of lamotrigine in mood disorders: clinical relevance and management.
Calabrese JR; Sullivan JR; Bowden CL; Suppes T; Goldberg JF; Sachs GS; Shelton MD; Goodwin FK; Frye MA; Kusumakar V
J Clin Psychiatry; 2002 Nov; 63(11):1012-9. PubMed ID: 12444815
[TBL] [Abstract][Full Text] [Related]
3. Epidermal Growth Factor Receptor Inhibitor Skin Rash Prophylaxis in a Community Oncology Setting.
Pepper MS; May M
J Adv Pract Oncol; 2018; 9(5):489-495. PubMed ID: 31086685
[TBL] [Abstract][Full Text] [Related]
4. Real-world analysis of the Celgene Global Drug Safety database: early discontinuation of lenalidomide in patients with myelodysplastic syndromes due to non-serious rash.
Weiss L; Gary D; Swern AS; Freeman J; Sugrue MM
Ther Clin Risk Manag; 2015; 11():1355-60. PubMed ID: 26379438
[TBL] [Abstract][Full Text] [Related]
5. Drugs as a Frequent Cause of Acute Rash in Patients after CD34
Klager S; Lacouture ME; Hannum M; Devlin SM; Maloy M; Pulitzer M; Jakubowski AA; Markova A
Biol Blood Marrow Transplant; 2019 Nov; 25(11):2172-2180. PubMed ID: 31306779
[TBL] [Abstract][Full Text] [Related]
6. Pan Canadian Rash Trial: A Randomized Phase III Trial Evaluating the Impact of a Prophylactic Skin Treatment Regimen on Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitor-Induced Skin Toxicities in Patients With Metastatic Lung Cancer.
Melosky B; Anderson H; Burkes RL; Chu Q; Hao D; Ho V; Ho C; Lam W; Lee CW; Leighl NB; Murray N; Sun S; Winston R; Laskin JJ
J Clin Oncol; 2016 Mar; 34(8):810-5. PubMed ID: 26573073
[TBL] [Abstract][Full Text] [Related]
7. A prospective crossover pilot study to evaluate the use of a topical wound gel in patients with cutaneous toxicity caused by epidermal growth factor receptor inhibitors.
Wong SF; Lindgren A; Mummaneni M; Byun T; Vasko C; Arenos R; Alexson E; Osann K
J Support Oncol; 2010; 8(5):202-8. PubMed ID: 21086877
[TBL] [Abstract][Full Text] [Related]
8. A Rare Case of Erythema Gyratum Repens Associated With Esophageal Carcinoma.
Matta A
Cureus; 2020 Aug; 12(8):e9971. PubMed ID: 32983674
[TBL] [Abstract][Full Text] [Related]
9. Skin rash induced by ritonavir-boosted darunavir is common, but generally tolerable in an observational setting.
Nishijima T; Gatanaga H; Teruya K; Mizushima D; Aoki T; Watanabe K; Kinai E; Honda H; Yazaki H; Tanuma J; Tsukada K; Kikuchi Y; Oka S
J Infect Chemother; 2014 Apr; 20(4):285-7. PubMed ID: 24507978
[TBL] [Abstract][Full Text] [Related]
10. [Rash in primary Epstein-Barr virus infection].
Lendak D; Mihajlović D; Turkulov V; Stefan Mikić S; Tomiç S
Med Pregl; 2012; 65(3-4):138-41. PubMed ID: 22788063
[TBL] [Abstract][Full Text] [Related]
11. Development of acneiform rash does not predict response to lapatinib treatment in patients with breast cancer.
Parma J; Pavlick A; Schiff R; Osborne CK; Chang JC; Rimawi M; Trivedi MV
Pharmacotherapy; 2013 Oct; 33(10):1126-9. PubMed ID: 23744830
[TBL] [Abstract][Full Text] [Related]
12. Correlation Between the Severity of Cetuximab-Induced Skin Rash and Clinical Outcome for Head and Neck Cancer Patients: The RTOG Experience.
Bar-Ad V; Zhang QE; Harari PM; Axelrod R; Rosenthal DI; Trotti A; Jones CU; Garden AS; Song G; Foote RL; Raben D; Shenouda G; Spencer SA; Harris J; Le QT
Int J Radiat Oncol Biol Phys; 2016 Aug; 95(5):1346-1354. PubMed ID: 27212198
[TBL] [Abstract][Full Text] [Related]
13. Utility of tissue elafin as an immunohistochemical marker for diagnosis of acute skin graft-versus-host disease: a pilot study.
Mahabal GD; George L; Peter D; Bindra M; Thomas M; Srivastava A; Mathews V; George B; Pulimood SA
Clin Exp Dermatol; 2019 Mar; 44(2):161-168. PubMed ID: 29882232
[TBL] [Abstract][Full Text] [Related]
14. Setting the Record Straight on Diaper Rash and Disposable Diapers.
Clark-Greuel JN; Helmes CT; Lawrence A; Odio M; White JC
Clin Pediatr (Phila); 2014 Aug; 53(9 suppl):23S-26S. PubMed ID: 24961777
[TBL] [Abstract][Full Text] [Related]
15. Rash management and treatment persistence of cancer patients treated with epidermal growth factor receptor inhibitors in the Truven MarketScan
Chen L; Brown J; Marmaduke DQ; Mayo C; Grau G; Lau YK; Obasaju CK
Support Care Cancer; 2018 Jul; 26(7):2369-2377. PubMed ID: 29423677
[TBL] [Abstract][Full Text] [Related]
16. Practical Management of Lenalidomide-Related Rash.
Tinsley SM; Kurtin SE; Ridgeway JA
Clin Lymphoma Myeloma Leuk; 2015 Jun; 15 Suppl():S64-9. PubMed ID: 26297281
[TBL] [Abstract][Full Text] [Related]
17. Rash in adult patients receiving lamotrigine to treat bipolar I disorder in Korea: a multicenter, prospective, naturalistic, open-label trial.
Woo YS; Bahk WM; Jon DI; Joo YH; Kim W; Seo JS; Ahn YM; Chung SK; Won SH; Shin YC; Yoon BH; Jung SH; Seok JH; Lee YS; Kim Y; Min KJ
Prog Neuropsychopharmacol Biol Psychiatry; 2009 Oct; 33(7):1147-52. PubMed ID: 19540298
[TBL] [Abstract][Full Text] [Related]
18. Risk factors for nevirapine-associated rash among HIV-infected patients with low CD4 cell counts in resource-limited settings.
Kiertiburanakul S; Sungkanuparph S; Charoenyingwattana A; Mahasirimongkol S; Sura T; Chantratita W
Curr HIV Res; 2008 Jan; 6(1):65-9. PubMed ID: 18288977
[TBL] [Abstract][Full Text] [Related]
19. Morbilliform Rash: An Uncommon Herald of SARS-CoV-2.
Kulkarni RB; Lederman Y; Afiari A; Savage JA; Jacob J
Cureus; 2020 Jul; 12(7):e9321. PubMed ID: 32850199
[TBL] [Abstract][Full Text] [Related]
20. Iodine Contrast Complex Rash Responding to Topical Steroids: A Case Report.
El Hussein M; Hamieh C; Zaghrini E
Am J Case Rep; 2021 Apr; 22():e928930. PubMed ID: 33824265
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
